Cellular Competition and Ageing Tissues

Tissues are not passive collections of identical cells. Many organs are maintained by cell populations that divide, differentiate, die, and compete for space or niche access. Cell competition is the name often given to processes in which relatively fitter cells or clones expand while neighbouring cells are removed, displaced, or diluted over time. [1] [2]

Who This Is Useful For

This page is useful for readers trying to understand why ageing tissues can become patchworks of different cell populations rather than uniformly older versions of their younger state. It is especially relevant for interpreting clonal haematopoiesis, epithelial mutation maps, stem-cell ageing, and claims that tissue decline is driven only by damaged-cell accumulation. [3] [4] [8]

What Cellular Competition Means

In developmental biology, cell competition was first studied as a way tissues remove cells that are less able to grow or survive relative to their neighbours. Later work extended the concept to adult tissue maintenance, cancer initiation, and stem-cell dynamics. The central point is comparative: a cell's fate depends not only on its own state but also on the state of nearby cells and the local tissue environment. [1] [2]

Competition can be neutral or directional. In neutral competition, equivalent stem cells replace one another stochastically over time. In directional competition, a genetic, epigenetic, metabolic, or microenvironmental difference changes the probability that one clone persists or expands. [2] [7]

Why It Matters in Ageing

Ageing increases the time available for somatic mutations, epigenetic drift, inflammatory exposures, and niche changes to accumulate. These differences can create variation among cells within the same tissue, giving some populations a relative advantage under local conditions. Reviews of stem-cell ageing describe both cell-intrinsic damage and cell-extrinsic niche changes as contributors to altered stem-cell function and selection. [7] [8]

This does not mean that every expanding clone is malignant or that every competitive interaction is harmful. Competition can remove less fit cells, preserve tissue architecture, or suppress early tumour growth in some models. The same general logic can also permit clones with altered behaviour to occupy more tissue space, which may become relevant to cancer risk or inflammatory disease. [2] [5] [6]

Examples Across Tissues

Clonal Expansion Is Not the Same as Cancer

Normal human tissues can contain many cancer-associated mutations without visible disease. In the ageing oesophagus, sequencing studies found extensive colonization by mutant clones in histologically normal tissue. This supports a somatic-evolution view of tissues, but it also shows why mutation presence alone is not enough to diagnose cancer. [3] [5]

Blood provides a parallel example. Age-related clonal haematopoiesis is defined by expanded blood-cell clones carrying somatic mutations in people without an overt haematological malignancy. Large cohort studies associate some forms of clonal haematopoiesis with higher risks of blood cancer, cardiovascular disease, and mortality, but absolute progression to malignancy remains limited for most individuals. [6] [9]

How Competition Connects to Other Hallmarks

Cellular competition overlaps with several ageing mechanisms rather than forming a separate, isolated hallmark. Genomic instability can generate clone-to-clone differences; epigenetic drift can alter stem-cell identity; inflammation can reshape local selection pressures; and stem-cell niche ageing can change which cells are best suited to persist. [1] [7] [8]

The competitive outcome depends on context. A clone that is advantaged in one tissue environment may not be advantaged in another. A mutation that helps cells expand in normal epithelium may not necessarily promote later tumour growth, and tissue architecture can constrain or redirect selection. [3] [5]

Evidence Quality and Interpretation

Evidence is strong that clonal expansion and cell competition occur in several adult tissues and become especially visible with ageing in renewing systems such as blood and epithelia. Human sequencing studies, lineage analyses, and experimental models all support the idea that aged tissues can contain competing cell populations. [3] [4] [6] [9]

Evidence is weaker when cellular competition is presented as a complete explanation for ageing across all tissues. Some organs renew slowly, some competitive processes may be protective, and many ageing phenotypes involve systemic metabolism, immune signalling, extracellular matrix change, and neuronal or endocrine regulation beyond local clone selection. [2] [8]

What This Does Not Mean

• It does not mean that all mutant clones are cancers or will become cancers. [3] [6]
• It does not mean that competition is always harmful; in some contexts it removes damaged or pre-malignant cells. [2] [5]
• It does not mean that ageing can be reduced to mutation accumulation, because niche state, inflammation, and epigenetic change can also shape cellular fitness. [7] [8]
• It does not mean that observations in one tissue automatically generalize to every organ system. [2] [8]

Practical Interpretation Examples

• If a study reports more mutant clones with age: That indicates altered tissue mosaicism, not necessarily disease by itself. [3] [4]
• If a clone expands: The expansion may reflect local fitness under the tissue conditions being studied, not universal biological superiority. [1] [2]
• If a competitive process removes altered cells: That can be protective in one setting while similar selection logic may be risky in another. [2] [5]

Summary

Cellular competition adds a population-level layer to ageing biology. It helps explain how tissues can become mosaics of competing cell states and clones, especially in renewing organs. The concept is most useful when treated as one mechanism among many: a way tissue context shapes which cells persist, not a single master theory of ageing. [1] [2] [8]

References

1. Baker, N. E. "Emerging mechanisms of cell competition." Nature Reviews Genetics (2020). https://www.nature.com/articles/s41576-020-0262-8
2. van Neerven, S. M. & Vermeulen, L. "Cell competition in development, homeostasis and cancer." Nature Reviews Molecular Cell Biology (2023). https://www.nature.com/articles/s41580-022-00538-y
3. Martincorena, I. et al. "Somatic mutant clones colonize the human esophagus with age." Science (2018). https://pmc.ncbi.nlm.nih.gov/articles/PMC6298579/
4. Fabre, M. A. et al. "The longitudinal dynamics and natural history of clonal haematopoiesis." Nature (2022). https://www.nature.com/articles/s41586-022-04785-z
5. Colom, B. et al. "Mutant clones in normal epithelium outcompete and eliminate emerging tumours." Nature (2021). https://www.nature.com/articles/s41586-021-03965-7
6. Jaiswal, S. et al. "Age-related clonal hematopoiesis associated with adverse outcomes." New England Journal of Medicine (2014). https://www.nejm.org/doi/full/10.1056/NEJMoa1408617
7. Ermolaeva, M. et al. "Cellular and epigenetic drivers of stem cell ageing." Nature Reviews Molecular Cell Biology (2018). https://www.nature.com/articles/s41580-018-0020-3
8. Brunet, A., Goodell, M. A. & Rando, T. A. "Ageing and rejuvenation of tissue stem cells and their niches." Nature Reviews Molecular Cell Biology (2023). https://www.nature.com/articles/s41580-022-00510-w
9. Genovese, G. et al. "Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence." New England Journal of Medicine (2014). https://www.nejm.org/doi/full/10.1056/NEJMoa1409405
10. Menthena, A. et al. "Activin A, p15INK4b signaling, and cell competition promote stem/progenitor cell repopulation of livers in aging rats." Gastroenterology (2011). https://pmc.ncbi.nlm.nih.gov/articles/PMC3087123/